284 related articles for article (PubMed ID: 17680191)
1. Role of urotensin II and its receptor in health and disease.
McDonald J; Batuwangala M; Lambert DG
J Anesth; 2007; 21(3):378-89. PubMed ID: 17680191
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System.
Clozel M; Binkert C; Birker-Robaczewska M; Boukhadra C; Ding SS; Fischli W; Hess P; Mathys B; Morrison K; Müller C; Müller C; Nayler O; Qiu C; Rey M; Scherz MW; Velker J; Weller T; Xi JF; Ziltener P
J Pharmacol Exp Ther; 2004 Oct; 311(1):204-12. PubMed ID: 15146030
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
Trebicka J; Leifeld L; Hennenberg M; Biecker E; Eckhardt A; Fischer N; Pröbsting AS; Clemens C; Lammert F; Sauerbruch T; Heller J
Hepatology; 2008 Apr; 47(4):1264-76. PubMed ID: 18318439
[TBL] [Abstract][Full Text] [Related]
4. Identification of novel Urotensin-II receptor antagonists with potent inhibition of U-II induced pressor response in mice.
Tandon R; Soni A; Singh RK; Sodhi R; Seth MK; Sinha S; Sahdev S; Dhage G; Das B; Dastidar SG; Shriumalla RK; Yonesu K; Marumoto S; Nagayama T
Eur J Pharmacol; 2020 Nov; 886():173391. PubMed ID: 32745605
[TBL] [Abstract][Full Text] [Related]
5. Cardiorenovascular effects of urotensin II and the relevance of the UT receptor.
Tölle M; van der Giet M
Peptides; 2008 May; 29(5):743-63. PubMed ID: 17935830
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.
Behm DJ; Harrison SM; Ao Z; Maniscalco K; Pickering SJ; Grau EV; Woods TN; Coatney RW; Doe CP; Willette RN; Johns DG; Douglas SA
Br J Pharmacol; 2003 May; 139(2):464-72. PubMed ID: 12770952
[TBL] [Abstract][Full Text] [Related]
7. Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues.
Behm DJ; McAtee JJ; Dodson JW; Neeb MJ; Fries HE; Evans CA; Hernandez RR; Hoffman KD; Harrison SM; Lai JM; Wu C; Aiyar NV; Ohlstein EH; Douglas SA
Br J Pharmacol; 2008 Oct; 155(3):374-86. PubMed ID: 18587423
[TBL] [Abstract][Full Text] [Related]
8. Human urotensin II as a link between hypertension and coronary artery disease.
Watanabe T; Kanome T; Miyazaki A; Katagiri T
Hypertens Res; 2006 Jun; 29(6):375-87. PubMed ID: 16940699
[TBL] [Abstract][Full Text] [Related]
9. Urotensin-II and UII-receptor expression and function in the rat adrenal cortex.
Albertin G; Casale V; Ziolkowska A; Spinazzi R; Malendowicz LK; Rossi GP; Nussdorfer GG
Int J Mol Med; 2006 Jun; 17(6):1111-5. PubMed ID: 16685423
[TBL] [Abstract][Full Text] [Related]
10. Urotensin II: its function in health and its role in disease.
Ong KL; Lam KS; Cheung BM
Cardiovasc Drugs Ther; 2005 Jan; 19(1):65-75. PubMed ID: 15883758
[TBL] [Abstract][Full Text] [Related]
11. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV
Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263
[TBL] [Abstract][Full Text] [Related]
12. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of blockade of the urotensin II system in systemic hypertension.
Krum H; Kemp W
Curr Hypertens Rep; 2007 Mar; 9(1):53-8. PubMed ID: 17362672
[TBL] [Abstract][Full Text] [Related]
14. Urotensin-II contributes to pulmonary vasoconstriction in a perinatal model of persistent pulmonary hypertension of the newborn secondary to meconium aspiration syndrome.
Simpson CM; Smolich JJ; Shekerdemian LS; Penny DJ
Pediatr Res; 2010 Feb; 67(2):150-7. PubMed ID: 19809374
[TBL] [Abstract][Full Text] [Related]
15. Urotensin II: Molecular Mechanisms of Biological Activity.
Svistunov AA; Tarasov VV; Shakhmardanova SA; Sologova SS; Bagaturiya ET; Chubarev VN; Galenko-Yaroshevsky PA; Avila-Rodriguez MF; Barreto GE; Aliev G
Curr Protein Pept Sci; 2018; 19(9):924-934. PubMed ID: 28875851
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of urotensin II, urotensin II-related peptide and urotensin II receptor mRNAs in the cardiovascular organs of hypertensive rats: comparison with endothelin-1.
Hirose T; Takahashi K; Mori N; Nakayama T; Kikuya M; Ohkubo T; Kohzuki M; Totsune K; Imai Y
Peptides; 2009 Jun; 30(6):1124-9. PubMed ID: 19463745
[TBL] [Abstract][Full Text] [Related]
17. Emerging roles of urotensin-II in cardiovascular disease.
Russell FD
Pharmacol Ther; 2004 Sep; 103(3):223-43. PubMed ID: 15464591
[TBL] [Abstract][Full Text] [Related]
18. The urotensin-II receptor antagonist palosuran improves pancreatic and renal function in diabetic rats.
Clozel M; Hess P; Qiu C; Ding SS; Rey M
J Pharmacol Exp Ther; 2006 Mar; 316(3):1115-21. PubMed ID: 16267137
[TBL] [Abstract][Full Text] [Related]
19. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
[TBL] [Abstract][Full Text] [Related]
20. Urotensin II: the old kid in town.
Onan D; Hannan RD; Thomas WG
Trends Endocrinol Metab; 2004; 15(4):175-82. PubMed ID: 15109617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
